Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE) - ANVISA Registration 80254180475

Access comprehensive regulatory information for CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180475 and manufactured by OXOID LIMITED. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Mar 05, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80254180475
2 Related Devices
Registration Details
ANVISA Registration Number: 80254180475
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

ProSpecT C. difficile Toxin A/B Microplate Assay
Risk Class III

Registration Details

80254180475

25351434052202411

04930429000139

Company Information

OXOID LIMITED
United Kingdom
PT: REINO UNIDO

Dates and Status

Mar 05, 2025

05/03/2035

09/18/2025 19:00:01

ProSpecT C. difficile Toxin A/B Microplate Assay
Risk Class III

Registration Details

80254180475

25351434052202411

04930429000139

Company Information

Dates and Status

Mar 05, 2025

05/03/2035

09/18/2025 19:00:01